Home › NDC Lookup › RxCUI directory › RxCUI 861668

Dihydroergotamine mesylate 0.5 MG/ACTUAT Metered Dose Nasal Spray — RxCUI 861668

RxNorm drug concept · Semantic clinical drug
RxCUI 861668 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI861668
Official nameDihydroergotamine mesylate 0.5 MG/ACTUAT Metered Dose Nasal Spray
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asDHE Mesylate 0.5 MG/ACTUAT Metered Dose Nasal Spray; dihydroergotamine mesylate 4 MG/mL Metered Dose Nasal Spray; dihydroergotamine mesylate 0.5 MG/ACTUAT (4 MG/ML) Metered Dose Nasal Spray
FDA products mapped6
Package NDCs mapped8
Reported Medicaid activity (SDUD)2,813 prescriptions · 10 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dihydroergotamine Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It works by activating certain serotonin receptors in the brain, which helps shrink swollen blood vessels and block pain signals from your trigeminal nerve — the nerve network resp...
  • What exactly does this injection do for my migraine?
  • Brekiya is injected just under the skin of your middle thigh. Remove the red needle cap, press the device firmly against a clean area of skin, then push and release the gray activa...
  • How do I use the Brekiya autoinjector at home?
📖 Read our full Dihydroergotamine Injection guide →

🕸️ Concept Web — How Dihydroergotamine mesylate 0.5 MG/ACTUAT Metered... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dihydroergotamine mesylate 0.5 MG/ACTUAT Metered Dose Nasal Spray RxCUI 861668

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Dihydroergotamine 3418
    • Dihydroergotamine mesylate 203176
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Migranal 42643
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dihydroergotamine Metered Dose Nasal Spray 2201618
    • Dihydroergotamine mesylate Metered Dose Nasal Spray 2648053
    • Dihydroergotamine Inhalant Product 1151867
    • Dihydroergotamine Nasal Product 1151869
    • Dihydroergotamine mesylate Inhalant Product 2661762
    • Dihydroergotamine mesylate Nasal Product 2663124
    • Dihydroergotamine Metered Dose Nasal Spray [Migranal] 2201620
    • Dihydroergotamine mesylate Metered Dose Nasal Spray [Migranal] 2654575
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Dihydroergotamine mesylate 0.5 MG/ACTUAT 861667
    • Dihydroergotamine mesylate 0.5 MG/ACTUAT Metered Dose Nasal Spray [Migranal] 861670
    • Dihydroergotamine mesylate 0.5 MG/ACTUAT [Migranal] 861669

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dihydroergotamine mesylate 0.5 MG/ACTUAT SCDC · 861667
  • Dihydroergotamine Metered Dose Nasal Spray SCDF · 2201618
  • Dihydroergotamine mesylate Metered Dose Nasal Spray SCDFP · 2648053
  • Dihydroergotamine Inhalant Product SCDG · 1151867
  • Dihydroergotamine Nasal Product SCDG · 1151869
  • Dihydroergotamine mesylate Inhalant Product SCDGP · 2661762
  • Dihydroergotamine mesylate Nasal Product SCDGP · 2663124

Brand-Name Concepts

  • Dihydroergotamine mesylate 0.5 MG/ACTUAT Metered Dose Nasal Spray [Migranal] SBD · 861670
  • Dihydroergotamine mesylate 0.5 MG/ACTUAT [Migranal] SBDC · 861669
  • Dihydroergotamine Metered Dose Nasal Spray [Migranal] SBDF · 2201620
  • Dihydroergotamine mesylate Metered Dose Nasal Spray [Migranal] SBDFP · 2654575
  • Migranal Inhalant Product SBDG · 1178704
  • Migranal Nasal Product SBDG · 1178706
  • Migranal BN · 42643

📦 FDA Products & Package NDCs

6 products · 8 package NDCs
8 package NDCs map to RxCUI 861668 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
24201-0463-08 8 VIAL in 1 CARTON (24201-463-08) / 1 mL in 1 VIAL Dihydroergotamine Mesylate Hikma Pharmaceuticals USA Inc. 2020-04-14
68682-0357-10 8 VIAL in 1 KIT (68682-357-10) / 1 mL in 1 VIAL Dihydroergotamine Mesylate Oceanside Pharmaceuticals 2013-03-18
69097-0503-27 8 VIAL in 1 KIT (69097-503-27) / 1 mL in 1 VIAL Dihydroergotamine Mesylate Nasal Cipla USA Inc. 2020-05-23
69097-0503-31 1 VIAL in 1 KIT (69097-503-31) / 1 mL in 1 VIAL Dihydroergotamine Mesylate Nasal Cipla USA Inc. 2020-05-23
70069-0880-08 8 CARTON in 1 KIT (70069-880-08) / 1 VIAL in 1 CARTON (7006... DIHYDROERGOTAMINE MESYLATE Somerset Therapeutics, LLC 2026-03-24
72888-0096-19 8 KIT in 1 KIT (72888-096-19) / 1 VIAL, GLASS in 1 KIT (728... Dihydroergotamine mesylate Advagen Pharma Ltd 2023-06-23
72888-0096-34 1 VIAL, GLASS in 1 KIT (72888-096-34) / 1 mL in 1 VIAL, GLA... Dihydroergotamine mesylate Advagen Pharma Ltd 2023-06-23
73352-0096-19 8 KIT in 1 KIT (73352-096-19) / 1 VIAL, GLASS in 1 KIT (733... Dihydroergotamine mesylate Trifluent Pharma, LLC 2025-07-08
Observed labelers: Advagen Pharma Ltd (2) · Cipla USA Inc. (2) · Hikma Pharmaceuticals USA Inc. (1) · Oceanside Pharmaceuticals (1) · Somerset Therapeutics, LLC (1) · Trifluent Pharma, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.